Immediate Impact
63 standout
Citing Papers
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Works of Edward Y. Chan being referenced
429 Long-term analysis of MASTERKEY-265 phase 1b trial of talimogene laherparepvec (T-VEC) plus pembrolizumab in patients with unresectable stage IIIB-IVM1c melanoma
2020
Management of the Solitary Pulmonary Nodule
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Edward Y. Chan | 535 | 259 | 342 | 57 | 948 | |
| John Alfred Carr | 641 | 513 | 226 | 46 | 1.1k | |
| D. Dean Potter | 535 | 213 | 427 | 62 | 1.2k | |
| Satoshi Watanabe | 501 | 243 | 168 | 61 | 893 | |
| Murat Danacı | 307 | 312 | 44 | 66 | 988 | |
| Matteo Sacchi | 524 | 221 | 33 | 75 | 1.1k | |
| Kenan Sönmez | 194 | 193 | 440 | 68 | 1.0k | |
| B. T. Le Roux | 553 | 512 | 259 | 67 | 1.0k | |
| Hideki Hyodoh | 404 | 311 | 90 | 69 | 935 | |
| James E. Seabold | 587 | 225 | 57 | 43 | 995 | |
| Yhi Wong | 495 | 321 | 24 | 79 | 1.0k |
All Works
Loading papers...